This video reviews updates on the treatment and biology of splenic and nodal marginal zone lymphoma.
In this video, Catherine Thieblemont, MD, PhD, of Hopital Saint-Louis in Paris, discusses updates on the treatment and biology of splenic and nodal marginal zone lymphoma.
Thieblemont gave a presentation on this topic during an education session at the 2017 American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9–12 in Atlanta.
Between the Lines Podcast: Tazemetostat in Relapsed/Refractory Follicular Lymphoma
November 3rd 2022Expert oncologist/hematologists Bruce Cheson, MD, FACP, and Steven Park, MD, discuss findings from the E7438-G000-101 trial and consider the efficacy of tazemetostat as treatment for relapsed or refractory follicular lymphoma.